DOCSLIB.ORG

Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000 Redbook 2000 Home > Food > Guidance, Compliance & Regulatory Information > Guidance Documents Food Redbook 2000 July 2000; Revised July 2007 Guidance for Industry and Other Stakeholders Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000 Additional copies are available from: Office of Food Additive Safety, HFS-200 Center for Food Safety and Applied Nutrition Food and Drug Administration 5001 Campus Drive College Park, MD 20740 (Tel)301-436-1200 http://www.cfsan.fda.gov/guidance.html U.S. Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nutrition July 2000; Updated July 2007 Note to reader: Individual chapters/sections of this internet version of "Redbook" are available as linked documents via the Table of Contents. The date of revision for each chapter and /or chapter section is provided in the Table of Contents and the individual documents. These revisions supersede previous versions of Redbook Table of Contents I Introduction 1 (July 2007) II. Agency Review of Toxicology Information Submitted in Support of the Safety Assessment of Food Ingredients (available in 1993 Draft "Redbook II" 2) III Recommended Toxicity Studies 3 (July 2007) IV. Guidelines for Toxicity Studies A. Introduction 4 (November 2003) B. General Recommendations for Toxicity Studies 000001 3/3/2010 Page 1 of 4 Redbook 2000 1. General Guidelines for Designing and Conducting Toxicity Studies 5 (November 2003) 2. Guidelines for Reporting Results of Toxicity Studies 6 (November 2003) 3. Pathology Considerations in Toxicity Studies 7 (July 2000) 4. Statistical Considerations in Toxicity Studies 8 (July 2000) 5. Diets for Toxicity Studies (available in 1993 Draft "Redbook II" 9) C. Guidelines for Specific Toxicity Studies 1. Short-Term Tests for Genetic Toxicity 10 (July 2000) a. Bacterial Reverse Mutation Test 11 (July 2000) b. In vitro Mammalian Chromosomal Aberration Test 12 (November 2003) c. In vitro Mouse Lymphoma TK 13 +/- Gene Mutation Assay 14 (April 2006) d. In vivo Mammalian Erythrocyte Micronucleus Test 15 (July 2000) 2. Acute Oral Toxicity Tests (available in 1993 Draft "Redbook II" 16) 3. Short Term Toxicity Studies a. Short-Term Toxicity Studies with Rodents 17 (November 2003) b. Short-Term Toxicity Studies with Non-Rodents 18 (November 2003) 4. Subchronic Toxicity Studies a. Subchronic Toxicity Studies with Rodents 19 (November 2003) b. Subchronic Toxicity Studies with Non-Rodents 20 (November 2003) 5. Chronic Toxicity Studies a. Chronic Toxicity Studies with Rodents 21 (July 2007) b. One-Year Toxicity Studies with Non-Rodents 22 (November 2003) 6. Carcinogenicity Studies with Rodents 23 (January 2006) 7. Combined Chronic Toxicity/Carcinogenicity Studies with Rodents 24 (July 2007) 8. In Utero Exposure Phase for Addition to Carcinogenicity Studies with Rodents 25 (July 2007) 9. Reproduction and Developmental Toxicity Studies a. Guidelines for Reproduction Studies 26 (July 2000) b. Guidelines for Developmental Toxicity Studies 27 (July 2000) 10. Neurotoxicity Studies 28 (July 2000) V. Additional Studies (available in 1993 Draft "Redbook II" 29) A. Introduction B. Metabolism and Pharmacokinetic Studies C. Immunotoxicity Studies VI. Human Studies 000002 3/3/2010 Page 2 of 4 Redbook 2000 A. Clinical Evaluation of Food Ingredients (available in 1993 Draft "Redbook II" 30) B. Epidemiology Studies 31 (October 2001) VII Glossary: Acronyms and Definitions 32 (April 2004) 1This guidance has been prepared by the Office of Food Additive Safety in the Center for Food Safety and Applied Nutrition at the U.S. Food and Drug Administration. 2Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food (also known as Redbook I), U.S. Food and Drug Administration, Bureau of Foods (now CFSAN), 1982. May be purchased from: National Technical Information Services (NTIS), 5285 Port Royal Road, Springfield, VA 22161, Telephone (703) 605-6000, NTIS Order Number PB83-170696. 3Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food 1993 Draft "Redbook II" Table of Contents 33 Links on this page: 1. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078044.htm 2. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078717.htm 3. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078310.htm 4. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078311.htm 5. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078315.htm 6. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078409.htm 7. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078318.htm 8. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078320.htm 9. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078717.htm 10. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078321.htm 11. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078330.htm 12. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078332.htm 000003 3/3/2010 Page 3 of 4 Redbook 2000 13. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078336.htm 14. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078336.htm 15. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078338.htm 16. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078717.htm 17. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078339.htm 18. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078342.htm 19. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078345.htm 20. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078346.htm 21. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078349.htm 22. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078348.htm 23. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078388.htm 24. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078393.htm 25. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078394.htm 26. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078396.htm 27. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078399.htm 28. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078323.htm 29. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078717.htm 30. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078717.htm 31. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078401.htm 32. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078404.htm 33. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredie ntsandPackaging/Redbook/ucm078717.htm 000004 3/3/2010 Page 4 of 4 Redbook 2000: I Introduction Home > Food > Guidance, Compliance & Regulatory Information > Guidance Documents Food Redbook 2000: I Introduction July 2007 Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000 Chapter I. Introduction Return to Redbook 2000 table of contents 1 This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the
Load more

Recommended publications
  • Alternative Testing Approaches in Environmental Safety Assessment
    Alternative Testing Approaches in Environmental Safety Assessment Technical Report No. 97 ISSN-0773-8072-97 Brussels, December 2005 Alternative Testing Approaches in Environmental Safety Assessment ECETOC TECHNICAL REPORT No. 97 © Copyright - ECETOC AISBL European Centre for Ecotoxicology and Toxicology of Chemicals 4 Avenue E. Van Nieuwenhuyse (Bte 6), B-1160 Brussels, Belgium. All rights reserved. No part of this publication may be reproduced, copied, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the copyright holder. Applications to reproduce, store, copy or translate should be made to the Secretary General. ECETOC welcomes such applications. Reference to the document, its title and summary may be copied or abstracted in data retrieval systems without subsequent reference. The content of this document has been prepared and reviewed by experts on behalf of ECETOC with all possible care and from the available scientific information. It is provided for information only. ECETOC cannot accept any responsibility or liability and does not provide a warranty for any use or interpretation of the material contained in the publication. ECETOC TR No. 97 Alternative Testing Approaches in Environmental Safety Assessment Alternative Testing Approaches in Environmental Safety Assessment CONTENTS SUMMARY 1 1. INTRODUCTION 3 2. BACKGROUND 5 2.1 Definitions 5 2.1.1 Definition of a protected animal 5 2.1.2 Ethical considerations of animal use 6 2.1.3 The three Rs 6 2.2 Information needs 7 2.2.1 The use of fish in ecotoxicology 7 2.2.2 Numbers of fish used 8 2.2.3 Regulatory tests - chemicals 8 2.2.4 REACH and its impact on the use of fish 9 2.2.5 Regulatory tests - effluents 9 2.3 Potential for alternatives 10 2.3.1 Reduction 10 2.3.2 Refinement 11 2.3.3 Replacement 11 2.4 Report structure 13 2.4.1 Atmosphere 14 2.4.2 Terrestrial hazard assessment 14 3.
    [Show full text]
  • Use of Polyphenolic Compounds in Dermatologic Oncology Adilson Costa, Emory University Michael Yi Bonner, Emory University Jack Arbiser, Emory University
    Use of Polyphenolic Compounds in Dermatologic Oncology Adilson Costa, Emory University Michael Yi Bonner, Emory University Jack Arbiser, Emory University Journal Title: American Journal of Clinical Dermatology Volume: Volume 17, Number 4 Publisher: Adis | 2016-08-01, Pages 369-385 Type of Work: Article | Post-print: After Peer Review Publisher DOI: 10.1007/s40257-016-0193-5 Permanent URL: https://pid.emory.edu/ark:/25593/s99z6 Final published version: http://dx.doi.org/10.1007/s40257-016-0193-5 Copyright information: © 2016, Springer International Publishing Switzerland (outside the USA). Accessed September 26, 2021 2:39 AM EDT HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Am J Clin Manuscript Author Dermatol. Author Manuscript Author manuscript; available in PMC 2018 April 16. Published in final edited form as: Am J Clin Dermatol. 2016 August ; 17(4): 369–385. doi:10.1007/s40257-016-0193-5. Use of Polyphenolic Compounds in Dermatologic Oncology Adilson Costa1, Michael Yi Bonner1, and Jack L. Arbiser1 1Department of Dermatology, Emory University School of Medicine, Atlanta Veterans Administration Medical Center, Winship Cancer Institute, 101 Woodruff Circle, Atlanta, GA 30322, USA Abstract Polyphenols are a widely used class of compounds in dermatology. While phenol itself, the most basic member of the phenol family, is chemically synthesized, most polyphenolic compounds are found in plants and form part of their defense mechanism against decomposition. Polyphenolic compounds, which include phenolic acids, flavonoids, stilbenes, and lignans, play an integral role in preventing the attack on plants by bacteria and fungi, as well as serving as cross-links in plant polymers. There is also mounting evidence that polyphenolic compounds play an important role in human health as well.
    [Show full text]
  • A Mutant Drosophila Homolog of Mammalian Clock Disrupts
    Cell, Vol. 93, 791±804, May 29, 1998, Copyright 1998 by Cell Press AMutantDrosophila Homolog of Mammalian Clock Disrupts Circadian Rhythms and Transcription of period and timeless Ravi Allada,*²³§ Neal E. White,³ Aronson et al., 1994; Shearman et al., 1997; Sun et al., W. Venus So,²³ Jeffrey C. Hall,²³ 1997; Tei et al., 1997). ²³ and Michael Rosbash* k In Drosophila, there are two well-characterized clock *Howard Hughes Medical Institute genes: period (per) and timeless (tim). Protein levels, ² NSF, Center for Biological Timing RNA levels, and transcription rates of these two genes ³ Department of Biology undergo robust circadian oscillations (Zerr et al., 1990; Brandeis University Hardin et al., 1990, 1992; Hardin, 1994; Sehgal et al., Waltham, Massachusetts 02254 1995; So and Rosbash, 1997). In addition, mutations § Department of Pathology in the two proteins (PER and TIM) alter or abolish the Brigham and Women's Hospital periodicity and phase of these rhythms, demonstrating Boston, Massachusetts 02115 that both proteins regulate their own transcription (Har- din et al., 1990; Sehgal et al., 1995; Marrus et al., 1996). Although there is no evidence indicating that the effects Summary on transcription are direct, PER contains a PAS domain, which has been shown to mediate interactions between We report the identification, characterization, and transcription factors (Huang et al., 1993; Lindebro et cloning of a novel Drosophila circadian rhythm gene, al., 1995). Most of these PAS-containing transcription dClock. The mutant, initially called Jrk, manifests dom- factors also contain the well-characterized basic helix- inant effects: heterozygous flies have a period alter- loop-helix (bHLH) DNA-binding domains (Crews, 1998).
    [Show full text]
  • Detection of Carcinogens As Mutagens in the Salmonella/Microsome Test
    Proc. Nat. Acad. Sci. USA Vol. 73, No. 3, pp. 950-954, March 1976 Medical Sciences Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion* (prevention of cancer and genetic defects/somatic mutation/environmental insult to DNA) JOYCE MCCANN AND BRUCE N. AMES Department of Biochemistry, University of California, Berkeley, Calif. 94720 Contributed by Bruce N. Ames, January 7, 1976 ABSTRACT About 300 carcinogens and non-carcinogens Non-Carcinogens. Classification as to non-carcinogenicity of a wide variety of chemical types have been tested for mu- is usually difficult because of the varying completeness and tagenicity in the simple Salmonella/microsome test. The test uses bacteria as sensitive indicators of DNA damage, and modes of treatment in many studies and the statistical limi- mammalian liver extracts for metabolic conversion of carcin- tations inherent in animal tests (4, 8-10). Recent criteria for ogens to their active mutagenic forms. There is a high corre- adequate carcinogenicity tests are much more stringent (4, lation between carcinogenicity and mutagenicity: 90% 8-10). The test should be of adequate duration (lifetime pre- (157/175) of the carcinogens were mutagenic in the test, in- ferred in rodents) in at least two animal species, at several cluding almost all of the known human carcinogens that dose levels, and positive controls should be of the same gen- were tested. Despite the severe limitations inherent in defin- ing non-carcinogenicity, few "non-carcinogens" showed any eral chemical type as the chemical under test. The applica- degree of mutagenicity [McCann et a]. (1975) Proc.
    [Show full text]
  • Downloads/Drugs/Guidancecomplianceregulatoryinformation/Guidances/UCM347725.Pdf
    Safety Assessment of Hydrogen Peroxide as Used in Cosmetics Status: Tentative Report for Public Comment Release Date: June 28, 2018 Panel Meeting Date: September 24-25, 2018 All interested persons are provided 60 days from the above date to comment on this safety assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Executive Director, Dr. Bart Heldreth. The 2018 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth Ph.D. This report was prepared by Lillian C. Becker, former Scientific Analyst/Writer, and Priya A. Cherian, Scientific Analyst/Writer. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 [email protected] ABSTRACT: The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) reviewed the safety of Hydrogen Peroxide, which is reported to function in cosmetics as an antimicrobial agent, cosmetic biocide, oral health care agent, and oxidizing agent.
    [Show full text]
  • Case 3:17-Cr-00249-BJD-JRK Document 89 Filed 03/14/18 Page 1 of 32 Pageid 361
    Case 3:17-cr-00249-BJD-JRK Document 89 Filed 03/14/18 Page 1 of 32 PageID 361 UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA JACKSONVILLE DIVISION UNITED STATES OF AMERICA v. CASE NO. 3:17-cr-249-BJD-JRK JOSHUA RYNE GOLDBERG DEFENDANT’S SENTENCING MEMORANDUM The Defendant, Joshua Ryne Goldberg, by and through counsel, Paul Shorstein, Shorstein, Lasnetski & Gihon, LLC, hereby submits the following Sentencing Memorandum setting forth all factors that the Court should consider in determining the type and length of sentence that is sufficient, but not greater than necessary, to comply with the statutory directives set forth in 18 U.S.C. §3553(a). BACKGROUND In 2015, law enforcement officials began investigating a certain online account that was posting threatening and other disturbing comments over the internet. Specifically, some of the internet discussion revolved around a potential attack of a 9/11 event in Kansas City, Missouri. That investigation ultimately led law enforcement officials to the Clay County home of Joshua Goldberg and his family. In the early morning hours of September 10, 2015, FBI agents and other law enforcement officials executed a search warrant inside 1 Case 3:17-cr-00249-BJD-JRK Document 89 Filed 03/14/18 Page 2 of 32 PageID 362 the Goldbergs’ home. They found Joshua Goldberg inside, as he always was. Joshua gave a statement that lasted a few hours despite not having slept for approximately 24 hours and not having taken his medication. Presumably, because the law enforcement officials found a severely mentally ill young man rather than what they expected as the source of the threatening internet activity, the government sought a criminal complaint (case number 3:15-mj-1170-J-JRK), which was filed on September 10, 2015, rather than more formal charges.
    [Show full text]
  • “Six-Pack” Testing Strategy: Influx of Modern in Vitro Techniques Gertrude-Emilia Costin, Ph.D., M.B.A
    Modernizing the “six-pack” testing strategy: influx of modern in vitro techniques Gertrude-Emilia Costin, Ph.D., M.B.A. Institute for In Vitro Sciences, Inc. (IIVS) NorCal SOT Fall Symposium 2017 The 3Rs 28 September 2017, San Francisco, CA, USA Perspectives, challenges, common goals and working together Safety/ Testing Labs Labeling/ Industry/ Regulatory Manufacturer Agency Consumer/ End-user Safety Presentation Outline Current regulatory climate – global acceptance of in vitro methods The reductionist concept of in vitro methods Drivers of in vitro methods advancement Beyond the “six-pack” battery of acute toxicity tests Acute oral toxicity Acute dermal toxicity (oral vs dermal route comparison) Acute inhalation toxicity Ocular irritation (the EPA OPP testing strategy) Skin irritation/corrosion Skin sensitization Modernizing the “six-pack” testing strategy: influx of modern in vitro techniques Current regulatory climate – global acceptance of in vitro methods The reductionist concept of in vitro models 1940s 1990s Whole animal Organ - Eyeball Tissue - Cornea Cell culture (Rabbit) (Enucleated chicken or (Resected bovine (Statens Seruminstitut rabbit eye) cornea) Rabbit cornea cells) “Less is more” Retinal Pigment Epithelium Semi-permeable Membrane Vascular network Nutrient channels Fibrinogen- endothelial cell administration channel Body-on-a-chip Organ-on-a-chip Tissue construct Cell culture (Human organotypic (Human retina) (Human EpiCorneal™ (Normal human microtissues) model) corneal epithelial cells) 2010s 2000s G.-E. Costin and H. A. Raabe. In vitro toxicology models. In: The Role of the Study Director in Non-clinical Studies. Pharmaceuticals, Chemicals, Medical Devices, and Pesticides. (Eds. William Brock, Barbara Mounho and Lijie Fu), John Wiley and Sons (2014). G.-E. Costin.
    [Show full text]
  • Epigenetic Modifications to Cytosine and Alzheimer's Disease
    University of Kentucky UKnowledge Theses and Dissertations--Chemistry Chemistry 2017 EPIGENETIC MODIFICATIONS TO CYTOSINE AND ALZHEIMER’S DISEASE: A QUANTITATIVE ANALYSIS OF POST-MORTEM TISSUE Elizabeth M. Ellison University of Kentucky, [email protected] Digital Object Identifier: https://doi.org/10.13023/ETD.2017.398 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Ellison, Elizabeth M., "EPIGENETIC MODIFICATIONS TO CYTOSINE AND ALZHEIMER’S DISEASE: A QUANTITATIVE ANALYSIS OF POST-MORTEM TISSUE" (2017). Theses and Dissertations--Chemistry. 86. https://uknowledge.uky.edu/chemistry_etds/86 This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • Toxicity and Hazard of Pesticides
    Pesticide Toxicity and Hazard April, 2017 Introduction Pesticide applicators should understand the hazards and risks associated with the pesticides they use. Pesticides vary greatly in toxicity. Toxicity depends on the chemical and physical properties of a substance, and may be defined as the quality of being poisonous or harmful to animals or plants. Pesticides have many different modes of action, but in general cause biochemical changes which interfere with normal cell functions. The toxicity of any compound is related to the dose. A highly toxic substance causes severe symptoms of poisoning with small doses. A substance with a low toxicity generally requires large doses to produce mild symptoms. Even common substances like coffee or salt become poisons if large amounts are consumed. Toxicity can be either acute or chronic. Acute toxicity is the ability of a substance to cause harmful effects which develop rapidly following exposure, i.e. a few hours or a day. Chronic toxicity is the ability of a substance to cause adverse health effects resulting from long-term exposure to a substance. There is a great range in the toxicity of pesticides to humans. The relative hazard of a pesticide is dependent upon the toxicity of the pesticide, the dose and the length of time exposed. The hazard in using a pesticide is related to the likelihood of exposure to harmful amounts of the pesticide. The toxicity of a pesticide can’t be changed but the risk of exposure can be reduced with the use of proper personal protective equipment (PPE), proper handling and application procedures. Pesticide Toxicity Some pesticides are dangerous after one large dose (acute toxicity).
    [Show full text]
  • Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Rules and Regulations
    43820 Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Rules and Regulations ENVIRONMENTAL PROTECTION standard can modify these guidelines as Agency experts and, in some instances, AGENCY needed for an individual test substance. presented at domestic and international The Agency uses a system where colloquia to solicit the views of 40 CFR Part 799 standardized guidelines are organized recognized experts and the regulated by testing endpoint and codified in a community. The draft harmonized [OPPTS±42193; FRL±5719±5] subpart of this part. When a test rule is guidelines are made available as public RIN 2070±AB76 promulgated, the test standard specified drafts. A notice is published in the in the test rule cross-references the Federal Register announcing their Toxic Substances Control Act Test guideline for the bulk of the testing availability and soliciting public Guidelines requirements. In this context, the public comment. is given notice of, and an opportunity to Seven of the 11 health effects test AGENCY: Environmental Protection comment on, the guidelines as they are guidelines that are being codified in Agency (EPA). applied in chemical-specific test rules. subpart H of 40 CFR part 799 have their ACTION: Final rule. This approach eliminates the need to origin in this harmonization process. A repeat the same test specifications for notice was published in the Federal SUMMARY: This rule establishes 11 Toxic each substance-specific test rule since Register of June 20, 1996, (61 FR 31522 Substances Control Act (TSCA) health most of the specifications for testing do (FRL±5367±7)) announcing the effects test guidelines in the Code of not change across substances.
    [Show full text]
  • Acute Toxicity Testing Without Animals: More Scientific and Less of a Gamble
    WellBeing International WBI Studies Repository 3-2005 Acute Toxicity Testing Without Animals: More Scientific and Less of a Gamble Gillian R. Langley British Union for the Abolition of Vivisection Follow this and additional works at: https://www.wellbeingintlstudiesrepository.org/appamet Part of the Bioethics and Medical Ethics Commons, Design of Experiments and Sample Surveys Commons, and the Laboratory and Basic Science Research Commons Recommended Citation Langley, G. (2005). Acute toxicity testing without animals. London, UK: BUAV. This material is brought to you for free and open access by WellBeing International. It has been accepted for inclusion by an authorized administrator of the WBI Studies Repository. For more information, please contact [email protected]. Acute Toxicity Testing Without Animals ~ “more scientific and less of a gamble” Report by Dr Gill Langley MA PhD MIBiol CBiol March 2005 British Union for the Abolition of Vivisection (BUAV) 16a Crane Grove London N7 8NN United Kingdom Email: [email protected] Web: www.buav.org Contents Foreword 3 1. Introduction 4 2. The Case Against Acute Toxicity Tests on Animals 5 2.1 Human relevance of acute toxicity tests on animals 6 2.2 Reliability of acute toxicity tests on animals 9 2.3 Practicalities of acute toxicity testing on animals 10 2.4 Animal suffering in acute toxicity tests 11 3. Classification and Labelling 11 4. High-throughput Prioritisation – Not Mass Animal Testing 12 5. Existing Data, Read-across and (Q)SARs for Acute Toxicity 13 5.1 Existing data 14 5.2 Read-across 14 5.3 (Q)SARs 15 6. Non-Animal Tests for Acute Toxicity 15 6.1 Rapid screening for acute toxicity 16 6.2 Fuller assessment for acute toxicity 17 6.2.1 Absorption in vitro and in silico 18 6.2.2 Plasma levels and target organ effects in vitro 19 6.2.3 Metabolism in vitro 20 6.2.4 Toxicokinetic modelling 20 7.
    [Show full text]
  • Endocrine Disruption
    Screening for Estrogen-mimicking Chemicals: An Assessment of the E-screen and Its Implications by Edmond Toy B.A.S. Civil Engineering and Values, Technology, Science, and Society Stanford University, 1993 Submitted to the Department of Civiland Environmental Engineering in Partial Fulfillment of the Requirements for the Degrees of Master of Science in Technology and Policy and Master of Science in Civil and Environmental Engineering at the Massachusetts Institute of Technology September 1995 © 1995 Massachusetts Institute of Technology. All rights reserved. Signature of Author: Department of Civil and Enviromental Engineering August 11, 1995 r'o / I' i /E Certified by: David H. Marks, Ph.D. James Mason Crafts Professor of Civil and Environmental Engineering Director, Program in Environmental Engineering Education and Research Thesis Supervisor A/ Certified by: Richard de Neufville, Ph.D. Professor of Civil and Environmental Engineering Chairman, Technology and Policy Program Accepted by: / 1- ! J'dseph M. Sussman, Ph.D. Chairman, Departmental Committee on Graduate Studies ;;ASSACHUS'T S INSTIlU'rE OF TECHNOLOGY Barker Eng OCT 25 1995 Screening for Estrogen-mimicking Chemicals: An Assessment of the E-screen and Its Implications by Edmond Toy Submitted to the Department of Civil and Environmental Engineering on August 11, 1995 in Partial Fulfillment of the Requirements for the Degrees of Master of Science in Technology and Policy and Master of Science in Civil and Environmental Engineering There is a growing concern that chemicals in the environment may be affecting the endocrine systems of wildlife and humans. Some scientists believe that these endocrine disrupting chemicals are responsible for a wide variety of cancer and noncancer effects.
    [Show full text]